BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-685@pharmaconomics
DTSTAMP:20260707T030117Z
DTSTART;VALUE=DATE:20260131
DTEND;VALUE=DATE:20260201
SUMMARY:VSTM Phase 1 — VS-7375 (estimated date)
DESCRIPTION:Phase 1 trial results for VS-7375 in multiple KRAS G12D solid tumors are due ~ Jan 31\, 2026. A clean hit validates the program\; a miss can gap the stock down hard.\n\nPrimary source: https://www.sec.gov/Archives/edgar/data/1526119/000110465926010036/tm265057d1_ex99-1.htm\n\nTrack it: https://pharmaconomics.com/e/685
URL:https://pharmaconomics.com/e/685
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:VSTM catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR